Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013–14: Results from the InNHOVE network

References

• Mereckiene J, Cotter S, Nicoll A, Lopalco P, Noori T, Weber J, D’Ancona F, Levy-Bruhl D, Dematte L, Giambi C, et al. Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11). Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull 2014; 19:20780; PMID:24786262
   PubMedGoogle Scholar
• Michiels B, Govaerts F, Remmen R, Vermeire E, Coenen S. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine 2011; 29:9159-70; PMID:21840359; http://dx.doi.org/10.1016/j.vaccine.2011.08.008
   PubMed Web of Science ®Google Scholar
• Saurwein-Teissl M, Lung TL, Marx F, Gschösser C, Asch E, Blasko I, Parson W, Böck G, Schönitzer D, Trannoy E, et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(−) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol Baltim Md 1950 2002; 168:5893-9
   Google Scholar
• Haq K, McElhaney JE. Immunosenescence: Influenza vaccination and the elderly. Curr Opin Immunol 2014; 29:38-42; PMID:24769424; http://dx.doi.org/10.1016/j.coi.2014.03.008
   PubMed Web of Science ®Google Scholar
• Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010; 17:CD004876; PMID:20166072
   PubMed Web of Science ®Google Scholar
• Rondy M, Puig-Barbera J, Launay O, Duval X, Castilla J, Guevara M, Costanzo S, de Gaetano Donati K, Moren A. 2011–12 Seasonal Influenza Vaccines Effectiveness against Confirmed A(H3N2) Influenza Hospitalisation: Pooled Analysis from a European Network of Hospitals. A Pilot Study. PloS One 2013; 8:e59681; PMID:23565159; http://dx.doi.org/10.1371/journal.pone.0059681
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Weekly influenza surveillance overview - 23 May 2014 - Surveillance report[Internet]. Available from: http://www.ecdc.europa.eu/en/publications/Publications/influenza-surveillance-overview-23-may-2014.pdf
   Google Scholar
• Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine 2010; 28:7381-8; PMID:20851086; http://dx.doi.org/10.1016/j.vaccine.2010.09.010
   PubMed Web of Science ®Google Scholar
• Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013; 31:2165-8; PMID:23499601; http://dx.doi.org/10.1016/j.vaccine.2013.02.053
   PubMed Web of Science ®Google Scholar
• Foppa IM, Haber M, Ferdinands JM, Shay DK. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013; 31:3104-9; PMID:23624093; http://dx.doi.org/10.1016/j.vaccine.2013.04.026
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Influenza virus characterisation Summary Europe, July 2014[Internet]. Available from: http://ecdc.europa.eu/en/publications/Publications/influenza-characterisation-report-july-2014.pdf
   Google Scholar
• Équipes de surveillance de la grippe. Epidemiological and virological influenza activity in mainland France: 2013–14 season (in French). BEH2014;
   Google Scholar
• Castilla J, Martínez-Baz I, Navascués A, Fernandez-Alonso M, Reina G, Guevara M, Chamorro J, Ortega MT, Albéniz E, Pozo F, et al. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis. Euro Surveillance 2014; 19(6).
   Google Scholar
• Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GCM, Vervaet G, Skepner E, Lewis NS, Spronken MIJ, Russell CA, et al. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 2013; 342:976-9; PMID:24264991; http://dx.doi.org/10.1126/science.1244730
   PubMed Web of Science ®Google Scholar
• Rimmelzwaan GF, Fouchier RAM, Osterhaus ADME. Age distribution of cases caused by different influenza viruses. Lancet Infect Dis 2013; 13:646-7; PMID:23886322; http://dx.doi.org/10.1016/S1473-3099(13)70181-6
   PubMed Web of Science ®Google Scholar
• Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945-52; PMID:19745214; http://dx.doi.org/10.1056/NEJMoa0906453
   PubMed Web of Science ®Google Scholar
• Davies JR, Grilli EA. Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses. Epidemiol Infect 1989; 102:325-33; PMID:2703026; http://dx.doi.org/10.1017/S0950268800030004
   PubMed Web of Science ®Google Scholar
• Smith DJ, Forrest S, Ackley DH, Perelson AS. Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci U S A 1999; 96:14001-6; PMID:10570188; http://dx.doi.org/10.1073/pnas.96.24.14001
   PubMed Web of Science ®Google Scholar
• Background Paper on Influenza Vaccines and Immunization. SAGE Working Group. 2012 [Internet]. 2013[cited 2013 Apr 19]; Available from: http://www.who.int/immunization/sage/meetings/2012/april/1_Background_Paper_Mar26_v13_cleaned.pdf
   Google Scholar
• Seyler T, Rondy M, Valenciano M, Moren A. Protocol for hospital-based case control studies to measure seasonal influenza vaccine effectiveness against laboratory confirmed influenza hospitalisations across the European Union and European Economic Area Member States. 2012.
   Google Scholar
• Calendrier vaccinal et recommandations vaccinales 2013 du ministère des affaires sociales et de la santé selon l’avis du Haut Conseil de la santé publique.; 2013 vaccination schedule and recommendations from the Haut conseil de la santé publique in France.
   Google Scholar
• Instituto de Salud Pública y Laboral de Navarra. Protocolo de vacunación antigripal 2013–2014. [Influenza vaccination protocol 2013–2014].
   Google Scholar
• Prevenzione e controllo dell’influenza: raccomandazioni per la stagione 2013–2014. [Prevention and control of influenza: recommendations for the season 2013–2014].
   Google Scholar
• MAHONEY FI, BARTHEL DW. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Md State Med J 1965; 14:61-5; PMID:14258950
   PubMedGoogle Scholar
• Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 2006; 11:193-206; PMID:16784338; http://dx.doi.org/10.1037/1082-989X.11.2.193
   PubMed Web of Science ®Google Scholar
• Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001.
   Google Scholar